drugset / Trial / NCT04795336

Melatonin Use After Primary Total Joint Arthroplasty

NCT04795336

Phase 1 Completed 294 enrolled NYU Langone Health
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effect of melatonin supplementation on patient sleep quality, length of stay, and opioid consumption following primary, unilateral, elective total hip or knee arthroplasty.

Timeline

Start
2021-07-12
Primary completion
2024-04-01
Completion
2024-04-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Melatonin Small molecule 5 mg

Indications